Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Templeton · SciRah

Researcher profile · Semantic Scholar

A. Templeton

Share profile

A. Templeton — researcher profile on SciRah

h-index: 46
Works: 206
Citations: 12K

Most-cited papers

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
S. Diem, S. Schmid, M. Krapf, L. Flatz +4 more
2017Lung Cancer921 citations
Semantic Scholar
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
J. Ethier, D. Desautels, A. Templeton, P. Shah +1 more
2017Breast Cancer Research635 citations Open access
Semantic Scholar
Neutrophils in cancer: prognostic role and therapeutic strategies
A. Ocaña, C. Nieto-Jiménez, A. Pandiella, A. Templeton
2017Molecular Cancer395 citations Open access
Semantic Scholar
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
G. Kulkarni, T. Hermanns, Yanliang Wei, B. Bhindi +16 more
2017Journal of Clinical Oncology280 citations Open access
Semantic Scholar
Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis.
F. Vera-Badillo, A. Templeton, I. Durán, A. Ocaña +6 more
2015European Urology206 citations
Semantic Scholar
Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.
A. Templeton, J. Knox, Xun Lin, R. Simantov +16 more
2016European Urology148 citations Open access
Semantic Scholar
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis.
J. Ethier, D. Desautels, A. Templeton, A. Oza +2 more
2017Gynecologic Oncology115 citations
Semantic Scholar
Relevance of randomised controlled trials in oncology.
I. Tannock, E. Amir, C. Booth, S. Niraula +4 more
2016The Lancet Oncology103 citations
Semantic Scholar
Under-reporting of harm in clinical trials.
B. Šeruga, A. Templeton, F. V. Badillo, A. Ocaña +2 more
2016The Lancet Oncology96 citations
Semantic Scholar
Informative censoring — a neglected cause of bias in oncology trials
A. Templeton, E. Amir, I. Tannock
2020Nature Reviews Clinical Oncology95 citations
Semantic Scholar
Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap.
A. Templeton, C. Booth, I. Tannock
2020Journal of Clinical Oncology89 citations
Semantic Scholar
Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
Galileo A Gonzalez-Conchas, L. Rodríguez-Romo, D. Hernández-Barajas, J. F. González-Guerrero +8 more
2018Cancer Treatment Reviews85 citations
Semantic Scholar
The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma
L. Khoja, E. Atenafu, A. Templeton, Ye Qye +5 more
2016Cancer Medicine83 citations Open access
Semantic Scholar
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
A. Tibau, C. Molto, A. Ocaña, A. Templeton +5 more
2018Journal of the National Cancer Institute79 citations Open access
Semantic Scholar
Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
R. Servant, M. Garioni, T. Vlajnic, M. Blind +12 more
2021Journal of Pathology78 citations Open access
Semantic Scholar
Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria
N. Turner, H. Wong, A. Templeton, S. Tripathy +10 more
2016International Journal of Cancer65 citations Open access
Semantic Scholar
Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer
Andrew J. Armstrong, P. Lin, C. Higano, C. Sternberg +8 more
2018Annals of Oncology63 citations Open access
Semantic Scholar
Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
B. Bojaxhiu, A. Templeton, O. Eliçin, M. Shelan +5 more
2018Radiation Oncology60 citations Open access
Semantic Scholar
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours
C. Fankhauser, A. Christiansen, C. Rothermundt, R. Cathomas +10 more
2021British Journal of Cancer51 citations Open access
Semantic Scholar
Bias in reporting of randomised clinical trials in oncology.
F. Vera-Badillo, Marc Napoleone, M. Krzyzanowska, S. Alibhai +6 more
2016European Journal of Cancer51 citations
Semantic Scholar
Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis.
R. Barua, A. Templeton, B. Šeruga, A. Ocaña +2 more
2018Clinics in oncology47 citations
Semantic Scholar
Efficacy, safety, tolerability and price of newly approved drugs in solid tumors.
T. Barnes, E. Amir, A. Templeton, Susana Gómez García +3 more
2017Cancer Treatment Reviews45 citations
Semantic Scholar
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
A. Hansen, I. Tannock, A. Templeton, E. Chen +9 more
2019The Oncologist43 citations Open access
Semantic Scholar
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression
A. Templeton, L. Gonzalez, F. Vera-Badillo, A. Tibau +6 more
2016PLoS ONE35 citations Open access
Semantic Scholar
Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies.
A. Srikanthan, F. Vera-Badillo, J. Ethier, Robyn Goldstein +4 more
2016Cancer Treatment Reviews32 citations
Semantic Scholar
Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
A. Tibau, A. Ocaña, G. Anguera, B. Šeruga +3 more
2016JAMA Oncology26 citations Open access
Semantic Scholar
Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: A systematic review and meta-analysis.
H. Goldvaser, I. Algorashi, D. Ribnikar, B. Šeruga +3 more
2017Cancer Treatment Reviews24 citations
Semantic Scholar
In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases
A. Ocaña, J. Pérez-Peña, Ana Alcaráz-Sanabria, Verónica Sánchez-Corrales +5 more
2016OncoTarget24 citations Open access
Semantic Scholar
Honorary and ghost authorship in reports of randomised clinical trials in oncology.
F. Vera-Badillo, Marc Napoleone, M. Krzyzanowska, S. Alibhai +6 more
2016European Journal of Cancer23 citations
Semantic Scholar
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors
K. Kudura, Nando Ritz, Tim Kutzker, M. Hoffmann +4 more
2022Cancers22 citations Open access
Semantic Scholar
Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression.
R. Adam, Laura Díez-González, A. Ocaña, B. Šeruga +2 more
2017Experimental and molecular pathology (Print)20 citations
Semantic Scholar
The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Milena Blaž Kovač, T. Pavlin, L. Cavka, D. Ribnikar +3 more
2023Journal of Geriatric Oncology19 citations Open access
Semantic Scholar
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel.
G. Sonpavde, G. Pond, A. Templeton, A. Fandi +4 more
2016European Urology19 citations
Semantic Scholar
Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review.
A. Neuenschwander, C. Lonati, L. Antonelli, A. Papachristofilou +10 more
2022European Urology Focus18 citations Open access
Semantic Scholar
The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
S. Fischer, C. Rothermundt, Odile Stalder, A. Terbuch +15 more
2023European Urology Open Science15 citations Open access
Semantic Scholar
Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
I. Rodríguez-Fernández, L. Rodríguez-Romo, D. Hernández-Barajas, Galileo A Gonzalez-Conchas +7 more
2019European Urology Oncology15 citations
Semantic Scholar
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy
A. Templeton, Á. Rodríguez-Lescure, A. Ruiz, E. Alba +17 more
2018Clinical and Translational Oncology15 citations
Semantic Scholar
Magnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA).
C. Valiente, M. Borrell, A. Fernández, A. Templeton +6 more
2018Annals of Oncology15 citations Open access
Semantic Scholar
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer
D. Ribnikar, I. Stukalin, Philippe Bédard, R. Hamilton +9 more
2020Current Oncology14 citations Open access
Semantic Scholar
Incidence of hypocalcemia in patients with castration-resistant prostate cancer treated with denosumab: Data from a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab administered every four weeks (q4w) versus every 12 weeks (q12w)—SAKK 96/12 (RE
S. Gillessen, R. von Moos, S. Hayoz, H. Hawle +16 more
2019Journal of Clinical Oncology11 citations
Semantic Scholar
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer
A. Ocaña, J. Pérez-Peña, Laura Díez-González, Verónica Sánchez-Corrales +4 more
2016Breast Cancer Research and Treatment11 citations Open access
Semantic Scholar
Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.
A. Bujosa, C. Molto, T. Hwang, J. C. Tapia +6 more
2021The Journal of the National Comprehensive Cancer Network10 citations Open access
Semantic Scholar
Clinical benefit of cancer drugs approved in Switzerland 2010–2019
R. Adam, A. Tibau, Consolación Molto Valiente, B. Šeruga +3 more
2022PLoS ONE9 citations Open access
Semantic Scholar
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
M. Pratsinis, C. Fankhauser, Katerina Pratsinis, J. Beyer +19 more
2022European Urology Open Science9 citations Open access
Semantic Scholar
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer
G. Sonpavde, G. Pond, A. Templeton, Eugene D. Kwon +1 more
2016Prostate Cancer and Prostatic Diseases9 citations
Semantic Scholar
Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer
B. Bojaxhiu, Dubravko Sinovcic, O. Eliçin, A. Templeton +6 more
2022Radiation Oncology8 citations Open access
Semantic Scholar
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
A. Christiansen, J. Lobo, C. Fankhauser, C. Rothermundt +10 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer
T. Wallrabenstein, J. D. Del Rio, A. Templeton, M. Buess
2020PLoS ONE8 citations Open access
Semantic Scholar
Vitamin D levels in Swiss breast cancer survivors.
M. Baumann, S. U. Dani, D. Dietrich, A. Hochstrasser +6 more
2018Swiss medical weekly8 citations Open access
Semantic Scholar
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition
K. Kudura, Nando Ritz, A. Templeton, Tim Kutzker +4 more
2023Journal of Clinical Medicine6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Amir×25
Invite
E. Amir — researcher profile on SciRah
A. Ocaña×20
Invite
A. Ocaña — researcher profile on SciRah
B. Šeruga×17
Invite
B. Šeruga — researcher profile on SciRah
I. Tannock×10
Invite
I. Tannock — researcher profile on SciRah

F. Vera-Badillo

×9

Invite

F. Vera-Badillo — researcher profile on SciRah

Invite

T. Hermanns — researcher profile on SciRah

Invite

A. Tibau — researcher profile on SciRah

C. Rothermundt×6

Invite

C. Rothermundt — researcher profile on SciRah

Invite

R. Cathomas — researcher profile on SciRah

S. Gillessen×6

Invite

S. Gillessen — researcher profile on SciRah

C. Fankhauser×5

Invite

C. Fankhauser — researcher profile on SciRah

Invite

J. Ethier — researcher profile on SciRah